21. New Scientist Ancient Ancestors Had Tummy Bug Too The stomachinfesting bacterium helicobacter pylori has been living in humans for at least 11,000 years - much longer than previously thought, say US researchers. http://www.newscientist.com/news/news.jsp?id=ns99993004

22. Helicobacter Pylori Persistence Biology And Disease Blaser And helicobacter pylori persistence biology and disease Martin J. Blaser1 and John C. Atherton2 http://tmsyn.wc.ask.com/r?t=an&s=hb&uid=24312681243126812&sid=343126

23. Helicobacter Pylori Vacuolating Cytotoxin, VacA, Is Responsible helicobacter pylori Vacuolating Cytotoxin, VacA, Is Responsible for Gastric Ulceration Akihiro Wada1 2 * , Eiki Yamasaki1 2 and http://tmsyn.wc.ask.com/r?t=an&s=hb&uid=24312681243126812&sid=343126

24. Helicobacter Pylori And Peptic Ulcer A monthly newsletter about evidencebased health care. http://www.jr2.ox.ac.uk/bandolier/bandopubs/hpyl/hpall.html

@import "../../styles/advanced.css"; Helicobacter Pylori and Peptic Ulcer A systematic review of effectiveness and an overview of the economic benefits of implementing what is known to be effective R A Moore MA DPhil Pain Research The Churchill Headington Oxford December 1994 Executive Summary Helicobacter pylori - background Introduction H pylori Evidence implicating H pylori in gastritis and peptic ulcer H pylori and ulcers How does H pylori cause gastritis and ulcers? Methods of diagnosing H pylori infection Invasive methods Culture Histology CLO test Non-invasive testing Breath testing Antibody measurement Quantitating antibody tests Antibody testing after H pylori eradication Prevalence UK prevalence Endoscopy studies Dyspepsia in seropositive and seronegative populations Incidence peptic ulcer bleeding Helicobacter pylori eradication and peptic ulcer Antibiotics and H pylori eradication H pylori eradication and relapse rates Effect of treatment on rebleeding rates Effect of eradication therapy on ulcer healing H pylori and dyspepsia Systematic review Conclusions H pylori and gastric cancer Background Gastric cancer and H pylori Epidemiological considerations Clinical guidelines on H pylori NIH Consensus Conference Endoscopy and H pylori testing Economic consequences of H pylori testing and eradication

25. PyloriGene Web Server Database of the genome of helicobacter pylori. Features a complete dataset of DNA and protein sequences linked to the relevant annotations and functional assignments. http://genolist.pasteur.fr/PyloriGene/

This page contains "Frames" and is viewable by a navigator that support this extension.

26. Helicobacter Pylori Cytotoxin VacA Increases Alkaline Secretion In helicobacter pylori cytotoxin VacA increases alkaline secretion in gastric epithelial cells Lucantonio Debellis1, Emanuele Papini2 http://tmsyn.wc.ask.com/r?t=an&s=hb&uid=24312681243126812&sid=343126

27. EMedicine – Peptic Ulcer Disease (PUD, Peptic Ulcers Symptoms) : Article B Dr. George Fantry reports on symptoms and treatment of stomach and duodenal peptic ulcers often caused by helicobacter pylori infections, NSAIDs, or stress. http://www.emedicine.com/med/topic1776.htm

(advertisement) Home Specialties Resource Centers CME ... Patient Education Articles Images CME Patient Education Advanced Search Consumer Health Link to this site Back to: eMedicine Specialties Medicine, Ob/Gyn, Psychiatry, and Surgery Gastroenterology Peptic Ulcer Disease Last Updated: May 6, 2005 Rate this Article Email to a Colleague Synonyms and related keywords: PUD Helicobacter pylori infection H pylori ... nonsteroidal anti-inflammatory drugs , NSAIDs, mucosal break, dyspepsia, heartburn, smoking stress , epigastric pain, belching, bloating, distention, fatty food intolerance, hematemesis , melena, gastrointestinal bleeding , Guaiac-positive stool, occult blood loss, succussion splash gastric outlet obstruction duodenal ulcers , perforation, gastrinoma Zollinger-Ellison syndrome multiple endocrine neoplasia syndrome MEN-I , antral G cell hyperplasia, systemic mastocytosis , basophilic leukemias, cirrhosis , chronic pulmonary disease, renal failure renal transplantation radiation-induced ulcers chemotherapy-induced ulcers , vascular insufficiency, crack cocaine duodenal obstruction AUTHOR INFORMATION Section 1 of 10 Author Information Introduction Clinical Differentials ... Bibliography Author: George T Fantry, MD

28. Helicobacter Pylori Cytotoxin VacA Increases Alkaline Secretion In helicobacter pylori cytotoxin VacA increases alkaline secretion in gastric epithelial cells Lucantonio Debellis1, Emanuele Papini2 http://tmsyn.wc.ask.com/r?t=an&s=hb&uid=24312681243126812&sid=343126

29. NEJM: Articles On Gastroenterology -- Pancreatitis, H. Pylori, And Gastroenterit Collection of medical research articles, case reports, reviews, and editorial commentary on helicobacter pylori, pancreatitis, gastroenteritis and other topics related to gastroenterology. http://content.nejm.org/cgi/collection/gastroenterology

HOME SEARCH CURRENT ISSUE PAST ISSUES ... HELP Please sign in for full text and personal services Gastroenterology The Gastroenterology collection covers topics such as Helicobacter pylori, pancreatitis, and gastroenteritis and includes research articles, case reports, reviews, and editorial commentary. Collections Home CME Exams Also see: Liver Disease Colorectal Cancer NEJM CareerCenter: See Latest Gastroenterology Jobs 1-20 (of 222 results) Show: All articles Original Articles Review Articles Special Articles Editorials Case Records of the MGH Clinical Implications of Basic Research Clinical Practice Clinical Problem-Solving Health Policy Reports Legal Issues in Medicine Occasional Notes Perspective Sounding Board Special Reports Most recent content (18 Aug 2005): Kasper D. L., Sahani D., Misdraji J. Extract Full Text PDF CME Exam N Engl J Med 2005; 353:713-722, Aug 18, 2005. Case Records of the Massachusetts General Hospital Earlier content (since Jan 1996): Brief Report:Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease Van Assche G., Van Ranst M., Sciot R., Dubois B., Vermeire S., Noman M., Verbeeck J., Geboes K., Robberecht W., Rutgeerts P.

30. Helicobacter Pylori H. pylori (helicobacter pylori) is a bacteria that can cause digestive illnesses, including gastritis and peptic ulcer disease. http://kidshealth.org/parent/infections/stomach/h_pylori.html

KidsHealth Parents Infections The bacteria H. pylori Helicobacter pylori ) usually don't cause problems in childhood. However, if left untreated the bacteria can lead to digestive illnesses , including gastritis (the irritation and inflammation of the lining of the stomach), peptic ulcer disease (characterized by sores that form in the stomach or the upper part of the small intestine, called the duodenum ), and even stomach cancer later in life. But even though the bacteria can cause these illnesses, experts believe that most H. pylori infections are "silent" and produce no symptoms. The bacteria are found everywhere in the world, but especially in developing countries, where up to 10% of children and 80% of adults can have laboratory evidence of an H. pylori infection - usually without having any symptoms. In industrialized countries, the infection is rare in children, and only about 40% of adults are infected. The risk of infection is higher for those who live in overcrowded or unsanitary conditions. What Are the Signs and Symptoms?

31. Magenerkrankungen Die Pharmaunternehmen Abbott und Altana machen auf das Bakterium helicobacter pylori als Ursache f¼r Magenbeschwerden aufmerksam. Diagnose und Therapiem¶glichkeiten werden vorgestellt, sowie Tipps zur Selbsthilfe beschrieben. http://www.magenerkrankungen.de/

Magengesundheit Magenbeschwerden Produktinformation Magentest Fragebogen Service Gebrauchsinformation Weiterempfehlung Für Interessierte Fachliteratur ... Lexikon Wir über uns Abbott und ALTANA Pharma Deutschland Impressum Datenschutz

32. Helicobacter Pylori And Ulcers: A Paradigm Revised When scientists identified helicobacter pylori as an infectious agent The story of the discovery of helicobacter pylori sounds like a chapter taken from http://www.faseb.org/opa/pylori/pylori.html

"Discovery consists of seeing what everybody has seen and thinking what nobody has thought." - Albert Szent Györgyi, 1937 Nobel Laureate in Physiology and Medicine Helicobacter pylori and Ulcers: a Paradigm Revised by Nancy A. Lynch, Ph.D. When scientists identified Helicobacter pylori as an infectious agent responsible for peptic ulcer disease, it completely transformed our understanding of the microbiology and pathology of the human stomach. That was in 1982. Before then, "no acid, no ulcer" succinctly described the accepted medical paradigm: stomach ulcers occurred when excess acid damaged the gastric mucosa, and treatment should be aimed at reducing or neutralizing that acid. Those who believed in psychosomatic theories of illness postulated even further that overproduction of the ulcer-causing acid was stimulated as a response to life's stresses-including overambitious mothers. We now know that many ulcers result from a bacterial infection, and that they are readily curable by treatment with antibiotics. The story of the discovery of Helicobacter pylori sounds like a chapter taken from the exciting book, Microbe Hunters. Written in 1926 by Paul de Kruif, it chronicled the discovery of the microbes causing the infectious diseases that ravaged the world's population of the time. It is the tale of two investigators from Western Australia. One observed a microorganism under his microscope and refused to accept previous explanations for its presence; the other used himself as a guinea pig in order to satisfy Koch's postulates, which indisputably establish an organism as causative agent for a specific disease (i.e., a pathogen). In fact, it recalls the story of Robert Koch himself, who conducted his experiments far from the medical mainstream in rural Germany, finally convincing the reluctant Berlin professors in 1882 that the bacilli he had isolated and studied actually caused tuberculosis.

33. Projectes De La S.C. De Digestologia Guia de pr ctica cl­nica per al diagn²stic i tractament de la disp¨psia i les malalties relacionades amb la infecci³ per helicobacter pylori a l’atenci³ prim ria. http://www.acmcb.es/societats/digest/project1.htm

Guies i Protocols Helicobacter pylori Helicobacter pylori Helicobacter pylori Digestiva Malaltia ulcerosa No digestiva Diabetes mellitus Tabac Alcohol Helicobacter pylori Malaltia ulcerosa Helicobacter pylori Seguiment Helicobacter pylori Cal eradicar Helicobacter pylori No cal eradicar Helicobacter pylori Helicobacter pylori que no han estat investigats adequadament. Les pautes recomanades es troben a la taula 2 Helicobacter pylori Pauta recomanada Omeprazol (20 mg/12h) o Lansoprazol (30 mg/12h) o Pantoprazol (40 mg/12h) Claritromicina (500 mg/12h) Amoxicil·lina (1.000 mg/12h) 7 dies de tractament Omeprazol (20 mg/12h) o Lansoprazol (30 mg/12h) o Pantoprazol (40 mg/12h) Claritromicina(500 mg/12h) 7 dies de tractament Omeprazol (20 mg/12h) o Lansoprazol (30 mg/12h) o Pantoprazol (40 mg/12h) Metronidazol (500 mg/8h) Tetraciclina (500 mg/6h) 14 dies de tractament Cal confirmar No cal confirmar R. Azagra, M Barenys, J Benavent, JM Bordas, JJ Mascort, F. Mearin, E Saperas Qui som Junta Directiva Juntes Anteriors Activitats ... Beques i premis

34. Information On Helicobacer Pylori Also Referred To As H. Pylori, Produced By Med Learn about helicobacter pylori (H. pylori) including what it is, how this infection is diagnosed, and how and why it is treated. http://www.medicinenet.com/helicobacter_pylori/article.htm

document.writeln(''); MedicineNet Home Digestion Home Page > Helicobacter Pylori Search Tips Printer-Friendly Format FREE Newsletters Email to a Friend ... Next Helicobacter Pylori Medical Author: Dennis Lee, M.D. Medical Editor: Jay Marks, M.D. What is Helicobacter pylori? How is H. pylori infection diagnosed? Why treat H. pylori? ... Who should receive treatment? What is Helicobacter pylori? Helicobacter pylori (H. pylori) is a bacterium that causes chronic inflammation of the inner lining of the stomach ( gastritis ) in humans. This bacterium also is the most common cause of ulcers worldwide. H. pylori infection is most likely acquired by ingesting contaminated food and water and through person to person contact. In the United States, 30% of the adult population is infected. (50% of infected persons are infected by the age of 60.) The infection is more common in crowded living conditions with poor sanitation. In countries with poor sanitation, 90% of the adult population can be infected. Infected individuals usually carry the infection indefinitely unless they are treated with medications to eradicate the bacterium. One out of every six patients with H. pylori infection will develop ulcers of the duodenum or stomach. H. pylori also is associated with

35. Sezione Di Studio SIGE Helicobacter Pylori E Patologie Correlate Sito ufficiale del Dipartimento. http://www.unibo.it/sezione-sige-hpylori/

Benvenuti nel sito di Queste pagine sono costruite con frame e quindi possono essere visualizzate solo con un browser che li supporta.

36. Bacteriology 330 Lecture Topics: Helicobacter PyloriBacteriology 3 helicobacter pylori is a spiralshaped, Gram-negative rod approximately 0.5 x In 1989, it was finally named helicobacter pylori based on functional and http://www.bact.wisc.edu/Bact330/lecturehelico2

Bacteriology at UW-Madison Helicobacter pylori: An Emerging Pathogen by Karrie Holston, Department of Bacteriology University of Wisconsin-Madison Description of Helicobacter pylori Helicobacter pylori is a spiral-shaped, Gram-negative rod approximately 0.5 x 3.0 micrometers in size. The catalase-positive organism has 4-6 sheathed flagella attached to one pole which allow for motility. History Barry Marshall and Robin Warren of Perth, Western Australia, discovered H. pylori in 1983. Originally, the organism was named Campylobacter pyloridis because it was structurally similar to other Campylobacter species, such as C. jejuni C. jejuni is a gut pathogen which has the ability to colonize the gastric mucosa. C. pyloridis was renamed Campylobacter pylori to fit in with the names of other enteric pathogens. In 1989, it was finally named Helicobacter pylori based on functional and enzymatic properties. Linkage to Gastrointestinal Disease Studies have linked H. pylori to gastrointestinal disease in humans. Even though H. pylori

37. MERIDIAN BIOSCIENCE: HpSA Helicobacter Pylori Stool Antigen Test Hpsa test to diagnose helicobacter pylori stomach infection and check the eradication simply by testing a fecal specimen. http://www.mdeur.com/hpsa.htm

Helicobacter pylori This is the "Helicobacter pylori" page from Meridian Bioscience Europe! Helicobacter pylori is a microrganism which can be found on the stomach mucosa of infected people. The infection is very frequent and mostly silent, but can produce gastritis, gastric ulcers and other dangerous pathologies. Meridian Bioscience is an innovative manufacturer of in-vitro diagnostic products, which has developed the first totally non-invasive test for diagnosing Helicobacter pylori infections. The product, named HpSA , can easily tell if a person is infected, by simply testing a small fecal specimen. I am a doctor More information? Click below I am a patient HpSA - Helicobacter pylori Stool Antigen test: diagnose Helicobacter stomach infection and check the eradication simply by testing a fecal specimen helicobacter pylori infection diagnosis hpsa HpSA HPSA stool faecal fecal antigen urea breath test UBT ubt urease CLO test RUT biopsy histology giemsa endoscopy gastroscopy symptoms NUD dyspepsia heartburn gastritis erosive GERD stomach ache gastric duodenal peptic ulcer cancer carcinoma malt MALT lymphoma maastricht consensus guidelines doctor patient management treatment eradication therapy follow-up triple chlarithromycin amoxicillin metronidazole

38. Bacteriology 330 Lecture Topics: Helicobacter PyloriBacteriology 330 Lect The genetics of helicobacter pylori are complex; there are many strains of H Once helicobacter pylori colonizes its host, it lives in the interface http://www.bact.wisc.edu/Bact330/lecturehelico1

Bacteriology at UW-Madison Helicobacter pylori by Tania Zeigler, Department of Bacteriology University of Wisconsin-Madison Biology of Helicobacter pylori Helicobacter are Gram-negative, aerobic or microaerophilic, spiral-shaped bacilli that are motile by way of flagella at one end of the cell. Closely related to Helicobacter are species of the genera Aquaspirillum Azospirillum Spirillum , and Camplyobacter . The genetics of Helicobacter pylori are complex; there are many strains of H . pylori which are distinguished by the human disease with which they are associated. Once Helicobacter pylori colonizes its host, it lives in the interface between the surface of gastric epithelial cells and the overlying mucus gel layer, often clustering at the junctions of epithelial cells. In addition H. pylori can also be found on top of the gastric epithelium in the duodenum and esophagus. It was not until 1983 that H . pylori was recognized as having any medical importance. Now, it has been proven that H. pylori infection is the main cause of chronic superficial gastritis and it is associated with both gastric and duodenal ulcers. Human Disease Peptic ulcer disease is a common clinical ailment, once thought to be caused by oversecretion of acid and pepsin, an enzyme of the stomach that promotes digestion by breaking down proteins. Researchers have found, however, that although the injury caused by acid and pepsin is necessary for the formation of ulcers, acid secretion levels of the majority of patients with gastric or duodenal ulcers are normal. An ulcer is now known to be the result of an imbalance between aggressive and defensive mechanisms in the stomach and duodenum. Part of that imbalance can be attributed to infection by

39. Management Of Helicobacter Pylori Infection- April 1, 2002 - American Family Phy helicobacter pylori is the cause of most peptic ulcer disease and a primary risk factor for Four Treatment Regimens for helicobacter pylori Infection http://www.aafp.org/afp/20020401/1327.html

Advanced Search AAFP Home Page Journals Vol. 65/No. 7 (April 1, 2002) Management of Helicobacter pylori Infection LINDA N. MEURER, M.D., M.P.H., and DOUGLAS J. BOWER, M.D., Medical College of Wisconsin, Milwaukee, Wisconsin Helicobacter pylori See page 1246 for definitions of strength-of-evidence levels contained in this article. A patient information handout on H. pylori infection, written by the authors of this article, is provided on page 1339. A PDF version of this document is available. Download PDF now (10 pages / 119 KB). More information on using PDF files. T he spiral-shaped, gram-negative bacterium Heliocobacater pylori is found in colonized gastric mucosa or adherent to the epithelial lining of the stomach. Acute infection, acquired most likely by ingestion of the organism, is most commonly asymptomatic but may be associated with epigastric burning, abdominal distention or bloating, belching, nausea, flatulence, and halitosis. Virtually all patients infected with H. pylori

40. Helicobacter Pylori Infection And Gastric Cancer Risk - May 15, 2004 - American helicobacter pylori Infection and Gastric Cancer Risk. Clinical Question Does treatment of helicobacter pylori infection reduce the risk of gastric cancer? http://www.aafp.org/afp/20040515/tips/2.html

Advanced Search Tips from Other Journals Previous Next POEM Helicobacter pylori Infection and Gastric Cancer Risk Clinical Question: Does treatment of Helicobacter pylori infection reduce the risk of gastric cancer? Setting: Population-based Study Design: Randomized controlled trial (double-blinded) Synopsis: Although chronic H. pylori infection is associated with an increased risk of developing gastric cancer, it is uncertain whether eradication treatment reduces this risk. A total of 1,630 healthy, asymptomatic adult carriers of H. pylori were identified by screening in the Fuzian province of China, a high-risk area. All of the patients underwent endoscopy, and 988 patients did not have precancerous lesions on study entry. Patients were assigned randomly in a double-blind fashion (uncertain allocation assignment) to receive H. pylori eradication treatment with a two-week course of 20 mg of omeprazole, a 750-mg combination of amoxicillin and clavulanate, and 400 mg of metronidazole, all twice daily, or placebo. Persons assessing outcomes were blinded to treatment group assignment. Ninety percent of patients were available for the primary analysis (on treatment) after eight years of follow-up. The authors diagnosed 18 new cases of gastric cancer. The risk of cancer development was not significantly reduced in participants who received

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 2     21-40 of 116    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20